Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Liabilities-and-Stockholders-Equity" stands at 129.55 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Liabilities and Stockholders Equity" stands at 129.55 Billion USD. This represents an increase of 10.23 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.22 percent compared to the value the year prior.
The 1 year change in percent is 10.22.
The 3 year change in percent is 20.98.
The 5 year change in percent is 44.26.
The 10 year change in percent is 27.97.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Liabilities and Stockholders Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Liabilities and Stockholders Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Liabilities and Stockholders Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Liabilities and Stockholders Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Liabilities and Stockholders Equity | 280,205,508,085.11 |